Sorbact is recommended by The National Institute for Health and Care Excellence in UK[5]View reference information
NICE medical technologies guidance mtg55 suggests that Leukomed Sorbact:
- Reduces SSI in caesarean section
- May reduce antibiotic use
- May reduce readmissions from wound complications
- Could save the NHS up to £5.3 million per year
- Cost savings are expected
Leukomed is a registered trademark of BSN Medical GmbH